Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,321,882
+$243,331 QoQ
Shares Held
9,227
-3.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
#1,854
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TIEMANN INVESTMENT ADVISORS, LLC holds $9,289,456 across 7 Drug Manufacturers - General names. ABBV ranks #3 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,451 | $2,654,240 | |
| 2 | LLY |
ELI LILLY & Co
|
2,149 | $2,577,575 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
9,227 | $2,321,882 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,492 | $834,222 | |
| 5 | AMGN |
Amgen Inc
|
1,119 | $405,212 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,122 | $268,093 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,961 | $228,232 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,321,882 | 9,227 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,078,551 | 9,557 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,297,923 | 10,057 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,355,456 | 10,173 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,917,454 | 10,330 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,213,578 | 10,565 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,894,282 | 10,660 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,164,578 | 10,961 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,910,046 | 11,136 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,027,865 | 11,136 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,707,149 | 11,016 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,688,998 | 11,331 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,519,889 | 11,281 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,825,742 | 11,456 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,886,311 | 11,672 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,573,478 | 11,724 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,530,815 | 16,524 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,685,190 | 16,564 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,265,106 | 16,729 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,796,035 | 16,650 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,904,291 | 16,906 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,845,800 | 17,056 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,695,005 | 15,819 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,282,405 | 14,641 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,464,354 | 14,915 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,116,716 | 14,657 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||